NCT05646576 Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy Status RECRUITING Phase NA
NCT05643248 To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects Status COMPLETED Phase EARLY_PHASE1
NCT05642884 Prehabilitation Feasibility Among Older Adults Undergoing Transplantation Status RECRUITING Phase NA
NCT05641324 A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) Status TERMINATED Phase PHASE1
NCT05636787 Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients Status RECRUITING Phase PHASE2
NCT05632380 ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) Status RECRUITING Phase PHASE1/PHASE2
NCT05623020 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant Status RECRUITING Phase PHASE3
NCT05620238 Home Treatment With Carfilzomib in Patients With Multiple Myeloma Status RECRUITING Phase N/A
NCT05618041 The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies Status RECRUITING Phase NA
NCT05594797 Human BCMA Targeted T Cells Injection(BCMA CAR-T)for Subjects With R/R MM Status RECRUITING Phase PHASE2
NCT05590377 A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT05587972 Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring Status ACTIVE_NOT_RECRUITING Phase NA
NCT05583617 A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05581875 A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05577884 Ultra-low-dose Whole-body CT Using AI-based CT Reconstruction in Patients With Multiple Myeloma Status UNKNOWN Phase N/A
NCT05573802 A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05572229 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma Status RECRUITING Phase PHASE2